Hepatitis C Cirrhosis Patients with Sustained Treatment Response Have Lower Risk of Death
- Details
- Category: HCV Treatment
- Published on Thursday, 27 December 2012 00:00
- Written by Liz Highleyman
Hepatitis C patients with cirrhosis who achieve sustained virological response to interferon-based therapy have a reduced risk of all-cause mortality, liver-related death or transplantation, liver cancer, and liver failure compared with non-responders, according to a study described in the December 26, 2012, issue of JAMA.
More Articles...
- Coverage of the 2012 AASLD Liver Meeting
- Hepatitis C Raises Risk of Both Liver-Related and Non-Liver Deaths
- FibroScan Liver Stiffness Measurement Predicts Liver Failure and Death
- Insulin Resistance Linked to Liver Disease Progression in HIV/HCV Coinfected Patients
- Hepatitis C Treatment Reduces HIV Progression and Death in HIV/HCV Coinfected
Web Design and Development by